CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.
Business Of Biotech
00:00
The Future of Biotech
Lawrence Cooper: We have technologies using a cytokine called Intilukin 12. Those trials are on enrolling, and we'll have data reported actually this year. All of these programs essentially have data to report out over the coming months.
Play episode from 36:31
Transcript
